BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rajkumar J, Sekar M, Mitra S. Safety and efficacy of oral HD-03/ES given for six months in patients with chronic hepatitis B virus infection. World J Gastroenterol 2007; 13(30): 4103-4107 [PMID: 17696230 DOI: 10.3748/wjg.v13.i30.4103]
URL: https://www.wjgnet.com/1007-9327/full/v13/i30/4103.htm
Number Citing Articles
1
Sandeep R. Varma, R. Sundaram, S. Gopumadhavan, Satyakumar Vidyashankar, Pralhad S. Patki. HD-03/ES: A Herbal Medicine Inhibits Hepatitis B Surface Antigen Secretion in Transfected Human Hepatocarcinoma PLC/PRF/5 CellsHepatitis Research and Treatment 2013; 2013: 1 doi: 10.1155/2013/125398
2
Current awareness: Pharmacoepidemiology and drug safetyPharmacoepidemiology and Drug Safety 2008; 17(4) doi: 10.1002/pds.1485
3
C. Girish, S.C. Pradhan. Liver Pathophysiology2017; : 605 doi: 10.1016/B978-0-12-804274-8.00044-8
4
Haiyong Jia, Diwakar Rai, Peng Zhan, Xuwang Chen, Xuemei Jiang, Xinyong Liu. Recent Advance of the Hepatitis B Virus Inhibitors: A Medicinal Chemistry OverviewFuture Medicinal Chemistry 2015; 7(5): 587 doi: 10.4155/fmc.15.19
5
Chetan Kantharia, Munesh Kumar, Mukesh Kumar Jain, Lokendra Sharma, Lokesh Jain, Anish Desai. Hepatoprotective Effects of Liv.52 in Chronic Liver Disease Preclinical, Clinical, and Safety Evidence: A ReviewGastroenterology Insights 2023; 14(3): 293 doi: 10.3390/gastroent14030021
6
Thanasekaran Jayakumar, Cheng-Ying Hsieh, Jie-Jen Lee, Joen-Rong Sheu. Experimental and Clinical Pharmacology ofAndrographis paniculataand Its Major Bioactive Phytoconstituent AndrographolideEvidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/846740
7
Premashis Kar, Mohammad Asim, Manash Pratim Sarma, Pralhad S. Patki. HD-03/ES: A promising herbal drug for HBV antiviral therapyAntiviral Research 2009; 84(3): 249 doi: 10.1016/j.antiviral.2009.09.013
8
Chandrashekaran Girish, Suresh Chandra Pradhan. Indian herbal medicines in the treatment of liver diseases: problems and promisesFundamental & Clinical Pharmacology 2012; 26(2): 180 doi: 10.1111/j.1472-8206.2011.01011.x